Turn hundreds of pages of regulatory language into your team's next move.
Quincy Can Do It
Quincy, Quorum's AI assistant, provides all your policy intelligence in one AI connected workspace. Built into Quorum Federal and Quorum State, Quincy is trained on 10+ years of Quorum's proprietary data and queries the entire government affairs ecosystem, including federal hearings, state committee transcripts, executive orders, agency documents, and uploaded PDFs, to give you insights you can actually trust.
Ask Quincy what any document means for your organization and get a clear, actionable answer in seconds.
You Ask Quincy
What does this executive order require federal agencies to do and what are the implications for organizations working in mental health policy?
Quincy Delivers*
Here's the full breakdown of the executive order and what it means for mental health policy organizations:
What the EO requires:
• FDA to provide National Priority Vouchers to psychedelic drugs with Breakthrough Therapy designation.
• FDA and DEA to create a Right to Try pathway for eligible patients to access psychedelic drugs.
• HHS to allocate at least $50 million to support states advancing psychedelic drug programs.
• HHS and FDA to collaborate with the VA and private sector on clinical trials and data sharing.
• The Attorney General to expedite rescheduling of Schedule I substances completing Phase 3 trials.
Implications for mental health policy organizations:
• Accelerated patient access — The Right to Try pathway and Priority Vouchers meaningfully shorten the timeline for eligible patients to access psychedelic therapies.
• New state partnership opportunities — The $50M HHS allocation opens direct funding pathways for state-level psychedelic drug programs. Organizations working with state health agencies should engage early.
• Veteran-focused research funding — VA collaboration directives create new avenues for organizations supporting veteran mental health.
• Expanded clinical trial networks — HHS/FDA/private sector coordination will broaden trial participation and data sharing standards.
• Rescheduling implications — Expedited DEA rescheduling of substances completing Phase 3 will reshape prescribing and reimbursement conversations.
Recommended next moves:
• Brief leadership on the $50M state partnership funding pathway.
• Identify which of your state coalition partners are best positioned to compete for HHS allocations.
• Coordinate with VA stakeholders on trial participation opportunities.
Full executive order available in Quorum for team review.
*Example shown for demonstration; actual results may vary.
Why Teams Use Quincy
Executive orders, agency press releases, and federal guidance drop constantly, and your team is expected to know immediately what each one means for your organization.
For example, Quincy breaks down the entire executive order in seconds: FDA prioritization, a new Right to Try pathway, $50 million allocated for state partnerships, VA collaboration directives, and what each one means for federal lobbying strategy. Your team can start planning the moment a document drops, not after a policy memo works its way through the organization. The same capability applies across any federal regulatory document — Environmental Impact Statements, proposed rules, Federal Register notices, agency guidance. If your organization needs to know what a federal document requires and by when, Quincy reads it.